Cancun all-inclusive Pharmacy CE seminar (adults only)
11/12/2027 - 11/14/2027
8:00 am - 1:00 pm
Where: Secrets the Vine Cancun
Topics include: topics: chronic pain, palliative care issues, hospice and end-of-life pain
HOTEL INFO: Please call us to assist with room reservation
Secrets the Vine Cancun
All-inclusive Group rate Deluxe Ocean View $293 per person per night double occupancy king bed, $283 per person per night double occupancy occupancy two queen beds, and $317 per person per night Preferred Club. Triple occupancy $280 per person per night. Pre and post available. All-Inclusive= room rate, all food and snacks, all drinks alcoholic or non-alcoholic, entertainment, taxes and gratuities. Certain sports activities may be extra.
https://www.hyattinclusivecollection.com/en/resorts-hotels/secrets/mexico/vine-cancun
Gregory Holmquist, Pharm.D., BCOP
Pain and Palliative Care Specialist
Dr. Holmquist is on the Board of Advisors of the American Society of Pain Educators. Over the past decade, he has been invited to present over 1,000 CME and CE lectures on pain management across the country. He shares practical and relevant clinical information, with a touch of humor, ensuring that audiences not only listen but also hear an important message on managing pain and making a difference in the lives of their patients.
Friday November 12, 2027
MANAGING PAIN AND SYMPTOMS OF CHRONIC PAIN, HOSPICE, AND PALLIATIVE CARE PATIENTS: KNOW YOUR PAIN PATIENTS
ACPE# TBA
Objectives:
1. Discuss the burden of opioid misuse and abuse on individuals and society.
2. State general assessment principles and types of tools used to assess pain.
3. Cite three common reasons certain patients are unable to obtain adequate pain control utilizing typical pain medications.
4. Describe three non-pharmacological modaltities that can assist with pain management.
5. Differentiate addiction, physical dependency, tolerance, and hyperalgesia.
6. Describe general management strategies for each of the following difficult painful disease states/challenging patients: fibromyalgia, uncontrolled neuropathic pain, patients with hyperalgesia, patients with a current or past history of addiction, non-communicative or elderly patient with dementia, and chronic non-cancer patient on what appears to be excessively high doses of opioids.
7. Identify typical characteristics of patients who would be identified as “high risk”, “moderate risk”, and “low risk” for misusing, abusing or diverting opioids.
————————————————————————————————–
Saturday November 13, 2027
UNDERSTANDING THE PALLIATIVE CARE AND HOSPICE PRACTICE IN MANAGING PAIN
ACPE# TBA
Objectives:
1. Define what “palliative care” is and state the overall pharmacological goals of palliative care.
2. State how “palliative care” and “hospice” differ in overall goals of care, types of symptoms/disease states typically encountered and pharmacological modalities employed.
3. State common symptoms experienced by palliative care patients with the following diseases: cancer, COPD, renal disease, liver disease, ALS, and Parkinson’s disease.
4. Compare and contrast core pharmacological principles for the use of opioids in palliative care patients versus hospice patients.
5. Propose a pharmacological management strategy for each of the following symptoms that can be associated with palliative care patients: nausea and vomiting, dyspnea, mental status changes (anxiety, agitation, hallucinations), constipation, pruritus, insomnia, anorexia or cachexia, weakness and fatigue, and muscle spasms.
6. Cite four general principles for medication optimization (deprescribing) to improve the pharmacological outcomes of palliative care patients.
————————————————————————————————-
Sunday November 14, 2027
UNDERSTANDING THE PHARMACOLOGY OF PAIN MANAGEMENT
ACPE# TBA
Objectives:
1. Describe the similarities and differences in the mechanism of action for opioids, cannabinoids, and gabapentenoids.
2. Compare and contrast the benefits, risks, and role of opioids, cannabinoids, and gabapentenoids in managing pain.
3. Describe the best practice model for properly monitoring patients who are started on opioids, gabapentenoids, and cannabinoids to minimize the risks of adverse reactions, over-dosage, and inappropriate compliance.
4. Compare and contrast the most common cannabinoids found in marijuana with regards to their benefits and risks in managing pain and other symptoms.
5. State the risks of combining opioids with benzodiazepines, alcohol, gabapentenoids, and cannabinoids.
6. Describe how to counsel patients and caregivers regarding the safe use on naloxone for opioid overdose.
7. Describe the roles and risks of using acetaminophen, NSAIDs, antidepressants, anticonvulsants, topical lidocaine, and other adjunctive medications in the management of pain.
8. State the most common side effects associated with opioid analgesics and how to prevent and treat these side effects.